x 

0 Activities
0 Activities
    • No Saved Activities

Education

  2. Home
  3. Disease Area
  4. Bronchiectasis
  5. Format
Page 5 of 5
Results 301 - 373 of 373
No image set
Exploring the Basic Mechanisms that Contribute to Development of Lung Fibrosis
No image set
Updates on Registry Enrollment and Growth of the Care Center Network
No image set
New Approaches to the Diagnosis of IPF
No image set
Exploring New Therapeutic Avenues for Managing PF
No image set
New Research on Mechanisms in the Development of PF
biosims-gastro1
Biosimilars: The New Era of Gastroenterology Management Considerations
No image set
Know Before You Go: IPF Grand Rounds Pre-learning
No image set
IPF Management Considerations
No image set
Perspectives on Side Effect Management
No image set
The Latest in IPF: Implications for Clinical Practice
No image set
Registry Data Provide Important Severity Indicators for PH
No image set
New Developments in the Diagnosis and Management of IPF
No image set
Palliative Care for Patients with IPF
No image set
Real World Experience in Patients with COPD
No image set
ICD-10 Codes and Nomenclature for Classification of PAH
No image set
Fleischner Society Update in Classification of IPF
No image set
Transbronchial Cryobiopsy for the Diagnosis of ILD
psoriasis-nurse
Psoriasis Management Considerations: What Would You Do?
psoriasis-case3
Jamie Develops Complications with Her Psoriasis
psoriasis-case2
Psoriasis: Three Case Studies in the Primary Care Setting
psoriasis-case1
Cindy Has a Complex Case of Psoriasis
No image set
Optimizing Patient Outcomes in IPF
9707-ella
Famous People with Diabetes: Ella Fitzgerald
9707-jerry
Famous People with Diabetes: Jerry Garcia
aims icon-comorb
Comorbidities and Selection of DMTs
aims icon-gut
The Gut Microbiota in MS
aims icon-early
Early MS: Induction Therapy and Escalation Strategies
aims icon-vitamin
Vitamin D: Modifiable Risk Factor and its Role in the Management of Patients with MS
No image set
The Importance of Early Referral and Treatment
No image set
How to Recognize and Diagnose IPF
No image set
What Is IPF?
No image set
What’s Next for IPF Therapy?
No image set
Applying the Evidence on Antifibrotic Agents for IPF
No image set
What Do the Experts Say about New Developments in the Diagnosis of ILD?
No image set
Is the delivery system a good match for your patients with COPD?
No image set
Stepping up or stepping down – which direction for COPD patients?
No image set
What’s the 2017 GOLD standard for managing patients with COPD?
No image set
UIP, IPF, NSIP, CHP: Making Sense of the Letters
t2diabetes-louise
Getting to Goal Can Be Difficult: Louise
t2diabetes-brian
Getting to Goal Can Be Difficult: Brian
IL-rheum-case3
Considering Biosimilars in Patients Failing their Initial Biologic
IL-rheum-case2
When to Switch? Biologically Experienced Patients with Spondyloarthritis
IL-rheum-case1
Innovator or Biosimilar for a Patient with Rheumatoid Arthritis
IL-gastro-case3
Ulcerative Colitis: What Can You Expect When a Patient is Switched to a Biosimilar?
IL-gastro-case2
Biosimilars in Patients with Crohn’s Disease Failing an Initial Biologic
IL-gastro-case1
Innovator or Biosimilar for a Patient with Ulcerative Colitis?
IL-derm-case3
Switching Between Biologics: Is a Biosimilar an Option?
IL-fund-case3
FDA Criteria: Biosimilar Approval, Manufacturing, & Naming
IL-fund-case2
What is the Difference Between a Biosimilar and a Generic?
IL-fund-case1
What is a Biologic?
No image set
New Strides in EGFR Inhibition for Non–Small Cell Lung Cancer
No image set
Pete - Work-Up of a Patient with Right Upper Lobe Mass and Metastases
No image set
Carl - High Suspicion of Lung Cancer: Setting the Stage with a Good Biopsy
biosims-full
Sorting it Out: Biologics, Biosimilars, Small Molecule Drugs, and Generics
biosims-green5
Are You Ready to Use Biosimilars in Your Practice?
biosims-full3
Health Care Providers’ Perspectives on Biosimilars: Based in Fact or Not?
biosims-green3
Pharmacovigilance and Biosimilars: Any Special Considerations?
biosims-full5
Interchangeability and Biosimilars: What will this Mean for Clinical Practice?
biosims-green8
Can a Biosimilar be Used for the Same Indications Approved for the Reference Biologic?
biosims-green
Drift and the Manufacturing of Biologics: What is it and Does it Matter?
No image set
Radiologic Features of IPF
No image set
Gwen: A lawyer with a history of MI has a dry cough and trouble with stairs
No image set
Individualizing Patient Education in Treatment Choice: Practical Strategies
lgmw-05
A 30 y/o Female w/2-year History of Shoulder Weakness and Elevated AST and ALT
lgmw-04
32 y/o Male w/Progressive Weakness, Dilated Cardiomyopathy & Respiratory...
biosims-full8
Biosimilars in Clinical Practice: Interchangeability and Extrapolation
9529-00028
Approach to Genetic Testing in Myopathies
9529-00014
Molecular Diagnosis of Limb-Girdle Muscle Weakness
No image set
Discovering New Drugs for IPF
No image set
New Trends in IPF
No image set
New Trends in IPF
No image set
Exciting IPF Developments from 2015 ERS
No image set
Exciting Developments from 2015 CHEST
Page 5 of 5

Search